How big is the Antibody-drug Conjugates Market?

The Antibody-drug Conjugates Market size is expected to reach USD 12.05 billion in 2024 and grow at a CAGR of 29.57% to reach USD 44.05 billion by 2029. Read More

What is the current Antibody-drug Conjugates Market size?

In 2024, the Antibody-drug Conjugates Market size is expected to reach USD 12.05 billion. Read More

Who are the key players in Antibody-drug Conjugates Market?

Seagen Inc., F Hoffmann-La Roche Ltd, Pfizer Inc, AstraZeneca and Gilead Sciences, Inc are the major companies operating in the Antibody-drug Conjugates Market. Read More

Which is the fastest growing region in Antibody-drug Conjugates Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Antibody-drug Conjugates Market?

In 2024, the North America accounts for the largest market share in Antibody-drug Conjugates Market. Read More

What years does this Antibody-drug Conjugates Market cover, and what was the market size in 2023?

In 2023, the Antibody-drug Conjugates Market size was estimated at USD 8.49 billion. The report covers the Antibody-drug Conjugates Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Antibody-drug Conjugates Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the emerging technologies impacting the Antibody Drug Conjugates Market?

The emerging technologies impacting the Antibody Drug Conjugates Market are a) AI-powered drug design b) Next-generation linker technologies c) Targeted delivery systems Read More

Antibody Drug Conjugates Companies

This report lists the top Antibody Drug Conjugates companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Antibody Drug Conjugates industry.